Study of the Safety and Leukostimulatory Activity of the Preparation "Panagen" in Patients With Breast Cancer

NCT02115984 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Panagen
DRUG: Placebo
PROCEDURE: Chemotherapy

Sponsor

Panagen, Limited Liability Company